Saks, Nordstrom, Ma...
Health Care: Drugs
Obagi Medical Products Inc. (OMPI: NASDAQ)
$23.98 -0.01 | -0.04%
04/25/13 - 04:00 PM ET
241.67K / 657.50K
Vol / Avg. Vol:23.99 / 23.99
Open / Prev. Close:23.98 - 24.03
Today's Range:10.70 - 25.60
52 Wk Range:76.45%
Performance YTD:TheStreet Rating:
Portfolios with OMPI
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- UserPART 7 JPMorgan 28th Annual...
- UserLast Day of the JPMorgan He...
- UserGrowth & Value
Latest OMPI Headlines from TheStreet
- The Five Dumbest Things on Wall Street: April 12
04.12.13 | 05:04 am - Merz Withdrawal Frees Obagi-Valeant Merger 04.09.13 | 01:04 pm
- Valeant Buys Obagi Medical for $360 Million 03.20.13 | 08:03 am
- Obagi Medical Products Inc. Stock Downgraded (OMPI) 11.08.12 | 04:11 am
- 5 Hated Stocks Set to Soar on Earnings 07.31.12 | 01:07 pm
- 5 Stocks Poised for Breakouts 07.13.12 | 12:07 pm
- 5 Stocks Poised for Breakouts 07.05.12 | 01:07 pm
- 8 Stocks Rising on Unusual Volume 06.15.12 | 01:06 pm
- Obagi Medical Stock Gaps Up On Today's Open (OMPI) 11.10.11 | 08:11 am
- Obagi Medical Products Inc. Stock Upgraded (OMPI) 08.11.11 | 07:08 am
Press Releases for OMPI
- Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Obagi Medical Products, Inc. - PR Newswire 04.25.13 | 08:04 am
- Valeant Pharmaceuticals International, Inc. Announces Receipt Of Approval From The Antimonopoly Committee Of Ukraine For Its Previously Announced Acquisition Of Obagi Medical Products, Inc. - PR Newswire 04.24.13 | 08:04 am
- Valeant Pharmaceuticals Announces Extension Of The Expiration Date For Its Previously Announced Tender Offer For All Outstanding Shares Of Common Stock Of Obagi Medical Products, Inc. - PR Newswire 04.23.13 | 08:04 am
- Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc. - PR Newswire 04.22.13 | 08:04 am
- Merz Pharma Group Withdraws Proposal To Acquire Obagi Medical Products - PR Newswire 04.08.13 | 07:04 am
- Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash - PR Newswire 04.03.13 | 08:04 am
- Merz Pharma Group Makes Superior Proposal To Acquire Obagi Medical Products - PR Newswire 04.02.13 | 07:04 am
- Rigrodsky & Long, P.A. Announces Investigation Of Obagi Medical Products, Inc. Buyout - PR Newswire 03.27.13 | 01:03 pm
- ATTENTION SHAREHOLDERS: Obagi Medical Products, Inc. (OMPI) Board Of Directors Investigated By The Young Law Firm For Possible Breaches Of Fiduciary Duty - Business Wire 03.26.13 | 12:03 pm
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of Obagi Medical Products, Inc. - PR Newswire 03.22.13 | 08:03 pm
Partner Headlines for OMPI
- Canadian Stocks Reverse Early Dip after March Factory Data Finds First Decline in Over 2 Years - NASDAQ 04.02.13 | 04:04 pm
- Canadian Stocks Rising Today; Blackberry, Valeant Helping Pace Gains - NASDAQ 03.20.13 | 05:03 pm
- Stocks Pop, But Declining Volume Dims Day's Gains - Investor's Business Daily 03.20.13 | 05:03 pm
- Stocks Up Ahead Of Fed Statement; Lennar At New High - Investor's Business Daily 03.20.13 | 01:03 pm
- Stocks Hold Up, Trade Mixed; Valeant, Obagi Lifted - Investor's Business Daily 03.20.13 | 12:03 pm
- How To Play The Cosmeceutical Market - Seeking Alpha 12.25.12 | 09:12 am
- Weekly CFO Sells Highlight: HAIN, OMPI, CAH - NASDAQ 09.17.12 | 02:09 pm
- 3 Healthcare Stocks With Positive Momentum - Seeking Alpha 09.01.12 | 08:09 am
- 4 Cash Loaded Biotech Stocks With Little Debt - Seeking Alpha 08.30.12 | 09:08 am
- Obagi REMOVED Shareholders' Rights Provision and 4 Stocks Riding the 52-Week High List - Wall St. Cheat Sheet 07.12.12 | 09:07 am
